Actual status of antiinterleukin-1 therapies in rheumatic diseases.
Geyer, Matthias
Actual status of antiinterleukin-1 therapies in rheumatic diseases. [electronic resource] - Current opinion in rheumatology May 2010 - 246-51 p. digital
Publication Type: Journal Article; Review
1531-6963
10.1097/BOR.0b013e3283373fa0 doi
Antibodies, Monoclonal--pharmacology
Antibodies, Monoclonal, Humanized
Antirheumatic Agents--therapeutic use
Drug Design
Humans
Immunologic Factors--therapeutic use
Interleukin 1 Receptor Antagonist Protein--pharmacology
Interleukin-1--antagonists & inhibitors
Receptors, Interleukin-1--antagonists & inhibitors
Recombinant Fusion Proteins--pharmacology
Rheumatic Diseases--drug therapy
Actual status of antiinterleukin-1 therapies in rheumatic diseases. [electronic resource] - Current opinion in rheumatology May 2010 - 246-51 p. digital
Publication Type: Journal Article; Review
1531-6963
10.1097/BOR.0b013e3283373fa0 doi
Antibodies, Monoclonal--pharmacology
Antibodies, Monoclonal, Humanized
Antirheumatic Agents--therapeutic use
Drug Design
Humans
Immunologic Factors--therapeutic use
Interleukin 1 Receptor Antagonist Protein--pharmacology
Interleukin-1--antagonists & inhibitors
Receptors, Interleukin-1--antagonists & inhibitors
Recombinant Fusion Proteins--pharmacology
Rheumatic Diseases--drug therapy